These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 3782427

  • 1. Treatment of neonatal hyperthyroidism due to Graves' disease with sodium ipodate.
    Karpman BA, Rapoport B, Filetti S, Fisher DA.
    J Clin Endocrinol Metab; 1987 Jan; 64(1):119-23. PubMed ID: 3782427
    [Abstract] [Full Text] [Related]

  • 2. Long term treatment of Graves' hyperthyroidism with sodium ipodate.
    Shen DC, Wu SY, Chopra IJ, Huang HW, Shian LR, Bian TY, Jeng CY, Solomon DH.
    J Clin Endocrinol Metab; 1985 Oct; 61(4):723-7. PubMed ID: 3928675
    [Abstract] [Full Text] [Related]

  • 3. The effect of repeated administration of ipodate (Oragrafin) in hyperthyroidism.
    Wu SY, Chopra IJ, Solomon DH, Johnson DE.
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1358-62. PubMed ID: 263735
    [Abstract] [Full Text] [Related]

  • 4. Further studies on the long-term treatment of Graves' hyperthyroidism with ipodate: assessment of a minimal effective dose.
    Shen DC, Wu SY, Chopra IJ, Shian LR, Florsheim W, Solomon DH.
    Thyroid; 1991 Dec; 1(2):143-6. PubMed ID: 1822359
    [Abstract] [Full Text] [Related]

  • 5. Use of sodium ipodate in management of hyperthyroidism in subacute thyroiditis.
    Chopra IJ, van Herle AJ, Korenman SG, Viosca S, Younai S.
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2178-80. PubMed ID: 7608275
    [Abstract] [Full Text] [Related]

  • 6. Comparative effects of sodium ipodate and iodide on serum thyroid hormone concentrations in patients with Graves' disease.
    Roti E, Robuschi G, Manfredi A, D'Amato L, Gardini E, Salvi M, Montermini M, Barlli AL, Gnudi A, Braverman LE.
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):489-96. PubMed ID: 3838710
    [Abstract] [Full Text] [Related]

  • 7. Treatment of hyperthyroidism with sodium ipodate (oragrafin) in addition to propylthiouracil and propranolol.
    Sharp B, Reed AW, Tamagra EI, Geffner DL, Hershman JM.
    J Clin Endocrinol Metab; 1981 Sep; 53(3):622-5. PubMed ID: 6894929
    [Abstract] [Full Text] [Related]

  • 8. Therapy of Graves' disease with sodium ipodate is associated with a high recurrence rate of hyperthyroidism.
    Martino E, Balzano S, Bartalena L, Loviselli A, Sica V, Petrini L, Grasso L, Piga M, Braverman LE.
    J Endocrinol Invest; 1991 Nov; 14(10):847-51. PubMed ID: 1687043
    [Abstract] [Full Text] [Related]

  • 9. Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin), an agent for oral cholecystography.
    Wu SY, Chopra IJ, Solomon DH, Bennett LR.
    J Clin Endocrinol Metab; 1978 Apr; 46(4):691-7. PubMed ID: 582597
    [Abstract] [Full Text] [Related]

  • 10. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
    Amino N, Yabu Y, Miki T, Morimoto S, Kumahara Y, Mori H, Iwatani Y, Nishi K, Nakatani K, Miyai K.
    J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
    [Abstract] [Full Text] [Related]

  • 11. Transient recurrence of hyperthyroidism after delivery in Graves' disease.
    Amino N, Miyai K, Yamamoto T, Kuro R, Tanaka F.
    J Clin Endocrinol Metab; 1977 Jan; 44(1):130-6. PubMed ID: 576228
    [Abstract] [Full Text] [Related]

  • 12. Effect of the combination of dexamethasone and sodium ipodate on serum thyroid hormones in Graves' disease.
    Arteaga E, López JM, Rodríguez JA, Michaud P, López G.
    Clin Endocrinol (Oxf); 1983 Nov; 19(5):619-27. PubMed ID: 6688973
    [Abstract] [Full Text] [Related]

  • 13. Sodium ipodate (oragrafin) in the preoperative preparation of Graves' hyperthyroidism.
    Tomaski SM, Mahoney EM, Burgess LP, Raines KB, Bornemann M.
    Laryngoscope; 1997 Aug; 107(8):1066-70. PubMed ID: 9261010
    [Abstract] [Full Text] [Related]

  • 14. Short-term hyperthyroidism followed by transient pituitary hypothyroidism in a very low birth weight infant born to a mother with uncontrolled Graves' disease.
    Higuchi R, Kumagai T, Kobayashi M, Minami T, Koyama H, Ishii Y.
    Pediatrics; 2001 Apr; 107(4):E57. PubMed ID: 11335778
    [Abstract] [Full Text] [Related]

  • 15. Comparison of methimazole, methimazole and sodium ipodate, and methimazole and saturated solution of potassium iodide in the early treatment of hyperthyroid Graves' disease.
    Roti E, Robuschi G, Gardini E, Montermini M, Salvi M, Manfredi A, Gnudi A, Braverman LE.
    Clin Endocrinol (Oxf); 1988 Mar; 28(3):305-14. PubMed ID: 3168311
    [Abstract] [Full Text] [Related]

  • 16. A radioimmunoassay for measurement of thyroxine sulfate.
    Chopra IJ, Santini F, Hurd RE, Chua Teco GN.
    J Clin Endocrinol Metab; 1993 Jan; 76(1):145-50. PubMed ID: 8421080
    [Abstract] [Full Text] [Related]

  • 17. Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3).
    Chopra IJ, Williams DE, Orgiazzi J, Solomon DH.
    J Clin Endocrinol Metab; 1975 Nov; 41(5):911-20. PubMed ID: 1242390
    [Abstract] [Full Text] [Related]

  • 18. Effect of sodium ipodate and iodide on free T4 and free T3 concentrations in patients with Graves' disease.
    Robuschi G, Manfredi A, Salvi M, Gardini E, Montermini M, d'Amato L, Borciani E, Negrotti L, Gnudi A, Roti E.
    J Endocrinol Invest; 1986 Aug; 9(4):287-91. PubMed ID: 3537101
    [Abstract] [Full Text] [Related]

  • 19. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M, Koizumi Y, Aizawa T, Yamada T, Takahashi Y, Watanabe T, Kamoi K.
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [Abstract] [Full Text] [Related]

  • 20. Sensitivity to lithium in treated Graves' disease: effects on serum T4, T3 and reverse T3.
    Burman KD, Dimond RC, Earll JM, Wright FD, Wartofsky L.
    J Clin Endocrinol Metab; 1976 Sep; 43(3):606-13. PubMed ID: 989049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.